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Introduction
Nuclei of unipotent somatic cells may become toti-or pluripotent after transfer into the metaphase cytoplasm of oocytes (2nd meiotic metaphase) or zygotes (1st mitotic metaphase) as shown by full-term development of the constructs or derivation of pluripotent embryonic stem (ES) cells (Egli et al., 2007) . The gene expression pattern of the donor nucleus undergoes extensive change within the recipient cytoplasm (reprogramming); presumably it must resemble that of a zygotic embryo in order for the clone to succeed. The prevalent view is that nuclear reprogramming does not follow a scheme and therefore is error-prone; but, in fact, the recipient cytoplasm might process the somatic nucleus as if it was a gametic nucleus. Therefore, it has been proposed that the limited developmental potential of cloned embryos is a result of skipping gametogenesis, which is necessary for complete programming and then reprogramming of key genes in the ooplasm (Fulka et al., 2004) .
Key embryonic genes include Oct4, which encodes a POUdomain transcription factor that is regarded as a 'gatekeeper' of pluripotency (Pesce and Schö ler, 2001) . Homozygous Oct4 mutant mouse embryos form morphologically normal blastocysts, but their inner cell mass (ICM) is not pluripotent (Nichols et al., 1998) . Experimental manipulation of Oct4 protein levels below 50% or above 150% of the physiologic level in mouse ES cells leads to in vitro differentiation along different lineages (Niwa et al., 2000) . During embryogenesis, ubiquitous Oct4 expression driven by the chicken b-actin promoter and cytomegalovirus enhancer affects mid-hindbrain patterning (Ramos-Mejia et al., 2005) , whereas Oct4 knock-down in the ICM by RNA interference impairs cardiogenesis (Zeineddine et al., 2006) . In the adult mouse, epithelial cells respond to a bulk increase in Oct4 level and become neoplastic (Hochedlinger et al., 2005) . Thus, faithful reprogramming of the Oct4 gene is necessary for cloned embryo development beyond the blastocyst stage, but we should not discount an earlier role of maternal Oct4 product in the ooplasm. In cumulus cell-derived mouse blastocysts, both the level and distribution of Oct4 expression is aberrant (Boiani et al., 2002) . Bortvin and colleagues found that only 62% of such cloned blastocysts expressed Oct4 and ten Oct4-related genes; the same genes were expressed in all ES cell-derived clones and fertilized embryos (Bortvin et al., 2003) . Nevertheless, ES cell-derived clones fail in large numbers at gastrulation (Jouneau et al., 2006) even though the donor nuclei may need less reprogramming than somatic nuclei (Blelloch et al., 2006) and may be more compatible with the recipient ooplasm (ES cells as 'earliest germ cells'; Zwaka and Thomson, 2005) .
An important question regarding nuclear reprogramming is whether changes of gene expression, in particular those concerned with pluripotency, occur randomly or follow a pattern. Investigating patterns of gene expression, however, is difficult. Gene expression studies based on pools of embryos are not suitable to address the question of random vs patterned change, as diversities are evened out. Studies of individual cloned embryos, on the other hand, produce too much detail to recognize patterns. Moreover, examination of transcript levels of a single gene in individual embryos could not distinguish a clone from a control embryo (Somers et al., 2006) . Cloned fetuses or newborns are even less suitable for gene expression studies as they already survived many critical phases of embryogenesis. However, because culture conditions can consistently change the level and distribution of Oct4 transcript in cumulus cell-derived mouse blastocysts (Boiani et al., 2005) , subsets of clones are produced, regardless of whether the cues from the culture medium affect the reprogramming process or simply select for competent clones. Therefore, gene analysis of defined subsets of the cloned embryo population might facilitate understanding of their gene regulation and help to revise the analytical approach that has been used so far.
In this study, we expose the structured diversity existing among cloned mouse morulae using Oct4-GFP transgenic nuclei (Boiani et al., 2002; Szabó et al., 2002) , live-cell confocal microscopy and basic image analysis. Morulae were viably sorted into three subsets according to mean GFP intensity and analyzed for GFP distribution, cell number, gene expression, ES cell and fetal potential. Functionally, developmental heterogeneity of clones can be reconciled with subsets of morulae that have different developmental competence within the embryo population. Although changes in gene expression may still be random until the morula stage, our results clearly preclude ongoing randomness with regard to blastocyst, ES cell and fetus formation. Regulatively, subsets of cloned morulae are characterized by small differences of transcripts levels of the pluripotency-associated genes Oct4, Nanog and Sox2. Whether there are other genes that show greater differences and are responsible for the effect, or clones indeed respond to small differences of gene expression unlike ICSI counterparts, these two possibilities point in the same direction: developmental potential of clones relates to levels of gene expression in a different way than fertilized embryos, and brings yet another level of complexity to nuclear reprogramming.
Results

2.1.
Subsets of embryos defined by intervals of Oct4-GFP intensity provide a new system to study nuclear reprogramming Patterns of GFP in blastocysts predict ES cell formation in cloned mouse embryos derived from Oct4-GFP transgenic cumulus cells (Boiani et al., 2002) . Transcription from the mouse Oct4 promoter begins at the 8-cell stage (Yoshimizu et al., 1999) , which suggests that the morula stage (%16-cell) clones may already harbor a bias towards developmental success and may thus reveal earlier aspects of nuclear reprogramming than previously suspected.
We devised an imaging protocol to measure GFP intensity without compromising embryo viability (Section 4). Seventyeight hours after transfer of Oct4-GFP cumulus cell nuclei into mouse ooplasts, more than 70% of the reconstructed oocytes attained the morula stage and variably expressed GFP under our experimental conditions. GFP intensity correlated to both the Oct4 mRNA level (r 2 = 0.943; Spearman test) and anti-Oct4 immunofluorescence signal (r 2 = 0.923; Spearman test; Table   1 ). After chromosome multicolor FISH, we could detect only basal levels of aneuploidy in blastomeres of 4-8 cell NT embryos, thereby confirming gene regulation and not dosage as the main cause for transcript level variations (Balbach et al., 2007) .
To correlate Oct4-GFP expression to further development of transgenic morulae, we acquired digital confocal sections of 562 NT and 213 ICSI morulae in a first series of 8 experiments (Table 2 ) and processed them with the software ImageJ while the morulae were allowed to form blastocysts in vitro. For each morula, a region of interest (ROI) was selected in the maximum projection image using the polygon tool of ImageJ. Essentially, pixels belonging to the embryo were included in the ROI, while those belonging to background were excluded (Supplementary Figure 1) . In addition to the mean gray (GFP) intensity, we also computed the 2nd, 3rd and 4th standardized moments of the probability distribution around the mean (standard deviation, SD; skewness; kurtosis). On the following day, 96 h after activation, the records of image analysis and blastocyst formation were matched. Blastocyst formation was encoded as '1' and failure thereof was encoded as '0'. Distributions of morulae according to GFP intensity and correlations of GFP intensity to blastocyst formation were different after NT and ICSI (Fig. 1) . Multivariate ANOVA computed by the statistical software JMP (Section 4) showed that blastocyst formation is best forecasted by GFP intensity in morulae, while the other three statistical moments showed lower correlation with blastocyst formation (Table 2 ) and were therefore excluded from subsequent analyses.
Oct4-GFP intensity correlated to blastocyst formation by 42% in cloned morulae with p < 0.01 (26% in ICSI morulae, p < 0.05, MANOVA; Table 2 ) and qualifies as an appropriate parameter to define subsets of clones. However, measured intensity values of GFP depend on many external factors, such as type and age of the light source, as well as the objective lens and camera, which are difficult to reproduce exactly in different laboratories. For better reproducibility, we therefore ranked the morulae by mean GFP intensity and divided this population into quantile intervals (0-33rd percentile, lowest GFP, subset 1; 34th-67th percentile, medium GFP, subset 2; 68th-100th percentile, highest GFP, subset 3; Fig. 2 ).
2.2.
Oct4-GFP subsets of cloned morulae differ at the developmental level
In a second series of 20 experiments, 794 NT and 546 ICSI morulae were allocated to GFP subsets as described, and followed through development to blastocyst ( Since blastocyst rate increased with GFP intensity, we investigated this association beyond the blastocyst stage. In a third series of 30 experiments, 3900 NT and 690 ICSI morulae were divided into GFP subsets, cultured to blastocyst and plated on feeders (Table 4) . Only a fraction of the resultant outgrowths were picked for ES cell derivation in order to even numbers between the subsets. Overall, cloned outgrowths yielded more ES cell lines than ICSI outgrowths with the same genetic background (25.6 ± 2.2% vs 12.6 ± 2.6%, p ( 0.05; t-test; Table 4 ). It should be noted that while these values are lower than previously reported for unsorted blastocysts by our laboratory (Cavaleri et al., 2006) , NT and ICSI blastocysts in the present study were processed side-by-side, thereby validating the differences. Among clones, ES cell derivation was not uniform but more successful for embryos of GFP subsets 3 and 2 than for subset 1 (36.4%, 27.3%, 9.4%; p ( 0.05; v 2 test; Table 4 ).
Among ICSI blastocysts, ES cell derivation was uniform across GFP subsets (p = 0.344; v 2 test; Table 4 ). Functional and biochemical analysis of all 125 ES cell lines derived for this study would have exceeded the scope of this study, therefore 18 NT ES cell lines (6 of each GFP subset) were selected for normal karyotype and all were confirmed to be pluripotent in vitro (positive immunocytochemically for SSEA-1, alkaline phosphatase and Oct4 protein; Supplementary Figure 2 ) and in vivo (germline contribution in chimeric fetuses after blastocyst injection; see Supplementary Results and Supplementary Figure 3 ). Although ES cell derivation is quite a reliable indicator of the quality of cloned blastocysts, the strongest evidence of embryo quality is the ability to form fetuses or pups. To test for this, we transferred equal numbers of NT embryos of subsets 1, 2, 3 into pseudopregnant females 18 h after imaging. To avoid bias by selection, all embryos were transferred regardless of their stage (morulae, cavitating morulae or blastocysts). On day E10.5, recipient wombs were dissected, implantation sites were counted, and deciduae were inspected for content (a fetus at Theiler stage 17 was expected). The results obtained in vivo confirmed those obtained in vitro. Ratios of decidua over the number of cloned embryos transferred in vivo (p = 0.004; v 2 test; Table 4 ) mirror the ratios of cloned blastocysts over morulae (p = 0.000; v 2 test; Table 3 ).
Fetal yields from decidua rank according to the original GFP subset that is, 3 > 2 > 1: subset 3 of cloned embryos yielded seven fetuses (20 decidua), subset 2 yielded one (11 decidua) and subset 1 did not yield any fetuses (5 decidua The box-plot distributions show that blastocyst formation corresponds to Oct4-GFP intensity in cloned but not in ICSI morulae. Morulae were allowed to develop further and were scored '1' or '0' according to blastocyst formation. Black dots correspond to individual morulae. Blue lines, average GFP intensity of the cloned and ICSI population; red boxes and whiskers, central and peripheral quartiles of the '0' and '1' subpopulation of morulae; green diamonds, 95% confidence interval of the mean of the '0' and '1' subpopulation of morulae.
subsets 1 and 2 merged together; Fisher's Exact Test for Count Data; Table 4 ).
2.3.
Small differences of pluripotency-associated gene expression among subsets suggest a rather uniform course of reprogramming
We analyzed GFP subsets of morulae and the resultant blastocysts for expression of pluripotency-associated (Oct4, Nanog, Sox2), trophectoderm (Cdx2), cumulus cell-specific (Ptgs2, Tnf6) and housekeeping (Tbp, Oct1) genes using Q-RT-PCR. Messenger RNA values were normalized first to an internal reference (Hprt mRNA) and then to an embryo calibrator (ICSI, subset 3) according to the DDCt method. Results were consistent over three replicates per sample and three independent samplings (10 embryos/sample), and are shown averaged in Figs. 3 and 4 (see Supplementary Table 1 for values).
Across the GFP subsets, cloned morulae showed similar expression level for housekeeping mRNA and small variations of Oct4, Nanog, Sox2 and Cdx2 mRNA (Fig. 3) . Between homologous subsets of cloned and ICSI morulae (e.g. NT 2 and ICSI 2), levels of Oct1 and Tbp were comparable (on average À10% and À4%, respectively) as expected for housekeeping genes whereas levels of Oct4 and Nanog were lower in cloned than in ICSI morulae (À23% and À20%, respectively); levels of Cdx2 were higher (+13%; Fig. 3 ). Sox2 was remarkably underexpressed in NT morulae compared to ICSI counterparts (À87%). At the blastocyst stage, gene expression profiles of clones resembled those of morulae except for Nanog mRNA, which turned higher (+40%), and Cdx2 mRNA, which turned lower (À23%; Fig. 4) . Levels of the cumulus cell-specific transcripts Ptgs2 and Tnf6 were between three and five orders of magnitude lower in cloned morulae than in cumulus cells and fell below a reliable limit of detection of Q-RT-PCR Table 2 and Supplementary Figure 4 for DNA sequences). We selected 12, 7 and 7 CpG sites located in the DE (positions À4168 through À2661), basal promoter (positions À224 through À33) and first exon (positions +119 through +328), respectively, and analyzed an average of 15 PCR clones for each of the three regions. The DE was substantially more 3 -Gene expression levels of morula stage embryos and cumulus cells for pluripotency-associated (Oct4, Nanog, Sox2, Cdx2), cumulus cell-specific (Ptgs2, Tnf6) and housekeeping (Tbp, Oct1) genes. X, subset; Y, expression level relative to ICSI subset 3. Three independent sets of data were pooled. Notations used in the chart: * : NT and ICSI differ at p < 0.05 within the subset; A, B, C: ICSI morulae differ across the subsets at p < 0.05; a, b, c: NT morulae differ at p < 0.05 across the subsets. Error bars indicate the standard deviation. CpG) in all samples analyzed (Fig. 5) .
Discussion
Using Oct4-GFP cumulus cell nuclei, we exposed differences in Oct4-GFP expression present amongst derivative cloned morulae, which corresponded with differences in Oct4. Based on the report by Niwa (Niwa et al., 2000) in which unphysiologic levels of Oct4 in mouse ES cells resulted in their differentiation, we postulated that different Oct4 levels would result in a bias in development of cloned embryos. We analyzed subsets of morulae that correspond with quantitative intervals of Oct4-GFP intensity, and we found that the blastocyst rate and the ES cell derivability of clones positively correlate to GFP intensity; correlation is minor for control morulae produced by ICSI under the same genotype and culture conditions. After derivation, NT-ES cells from all GFP subsets contributed to gonads of chimeric fetuses at comparable frequencies, supporting the concept that ES cells from different sources are functionally indistinguishable (Brambrink et al., 2006; Wakayama et al., 2006) . The artificial process of ES cell derivation seems to exert such a tremendous selective pressure on blastocyst cells that those surviving will be very similar. Therefore, the validity of statements about reprogramming after somatic cell nuclear transfer based on established ES cell lines might be limited. For this reason we probed the cloned embryos for fetal development. Development through E10.5 (Theiler stage 17) is an appropriate landmark to assess the restoration of pluripotency after nuclear transfer, because losses suffered by clones at later stages are more likely to be the outcome of differentiation problems; indeed, ES cell-derived mouse clones still suffer high losses at gastrulation even though ES cells are pluripotent (Jouneau et al., 2006) . After transfer of cloned embryos in vivo at E4.5 and recovery at E10.5, we observed a positive association between the level of Oct4-GFP and the rate of fetal formation. Mouse cloning imposes well known limitations on absolute numbers and prevented our result (p P 0.053) from crossing the significance threshold. Out of curiosity, we estimated the size each subset should attain, in order to confirm differences between subsets, if the level of confidence was 5% and the v 2 test had 90% power (Section 4): size should be 246 instead of the current 72 or 73 embryos per subset. Typically, a cloned embryo is held superior if it resembles a fertilized embryo in terms of global gene expression with special regard to key genes. Among the three nodes of the pluripotency gene network that we analyzed, we found that transcript levels of Oct4 and Nanog co-varied with Oct4-GFP intensity in both cloned and fertilized embryos, whereas Sox2 mRNA was barely detectable in clones. A degree of covariance may be expected since Oct4, Sox2 and Nanog regulate their own gene expression via positive-feedback loops through their Oct-Sox enhancers (Boyer et al., 2005; Chew et al., 2005; Kuroda et al., 2005; Loh et al., 2006; Okumura-Nakanishi et al., 2005; Rodda et al., 2005; Tomioka et al., 2002) . The recent finding that Nanog promotes pluripotency transfer after cell fusion (Silva et al., 2006 ) is reflected in the close relationship between levels of Nanog transcript in clone subsets 1, 2, 3 (Figs. 3 and 4) and their developmental ability in the current study (Tables 3 and 4) . Striking was the deficit of Sox2 transcript in cloned embryos (13% and 35% of the ICSI value at morula and blastocyst stage, respectively) in the presence of substantial levels of Oct4 (77% and 62%), Nanog (80% and 140%) and Cdx2 (113% and 77%) mRNA. Previously, ES cells could not be derived from Sox2 À/À mouse blastocysts obtained from heterozygous intercross (Avilion et al., 2003) , therefore it is rather surprising that we succeeded here from -Gene expression levels at the blastocyst stage for pluripotency-associated (Oct4, Nanog, Sox2, Cdx2) and housekeeping (Tbp, Oct1) genes. X, subset; Y, expression level relative to ICSI subset 3. Three independent sets of data were pooled. Notations used in the chart: * : NT and ICSI differ at p < 0.05 within the subset; A, B, C: ICSI morulae differ across the subsets at p < 0.05; a, b, c: NT morulae differ at p < 0.05 across the subsets. Error bars indicate the standard deviation.
-4 1 6 8 -3 9 4 5 -3 3 4 7 -2 6 6 1 -2 2 4 -3 3 + 1 1 9 + 3 2 8 cloned blastocysts lacking 65% of the physiologic Sox2 mRNA level (although the absolute amount left may be sufficient). In fact, a deficit of Sox2 gene expression is more consistent with the low postimplantation ability of clones, as also pointed out independently by others (Li et al., , 2006 . Discussing transcript levels and their possible consequences for cloned embryo development is important but it must be cautious. It is hard to tell if mRNA deviations are really relevant to development or not, since cell phenotypes depend ultimately on protein rather than transcript level, and quantitative protein data for cloned mouse embryos are not available, to date. If a deficit of mRNA corresponded with a deficit of protein, then a deficit of Sox2 might destabilize the pluripotency network because Sox2 is known to stabilize the pluripotent state by maintaining the requisite level of Oct4 in mouse ES cells (Masui et al., 2007) . If a dose-effect respose of Oct4 applied to cloned mouse embryos as it does to mouse ES cells (Niwa et al., 2000) , then a 23-38% deviation from the ICSI level (assumed normal) could have important consequences for cloned embryo gastrulation, because the average deficit of the whole blastocyst (38%) could be disproportionally higher in the ICM of some embryos. The level of Cdx2 mRNA is similar across subsets of NT and ICSI blastocysts, albeit slightly lower in the clones. Lower transcript level may cause hypofunction of the trophectoderm and therefore might explain a deficit in implantation of NT blastocysts in utero while ES cell derivation is normal: the time-window for implantation in the uterus is defined and likely unforgiving to a defective trophectoderm, while NT blastocysts are plated zona-free on feeders that are equally receptive over time and ES cell derivation is possible even from Cdx2 deficient blastocysts (Meissner and Jaenisch, 2006), To summarize, the genes we analyzed are all important; if their defects were additive or combinatorial, then it would be reasonable to expect no development at all after NT. Since development does take place, dependence on these genes is not all-or-nothing but may follow Liebig's Law of the Minimum (Ploeg et al., 1999) , a principle developed in agricultural science whereby plant growth is limited by the scarcest resource -in case of our clones, that would be Sox2.
While activation of pluripotency-associated genes is clearly important, successful cloning by nuclear transfer may also require silencing of genes that had been actively transcribed in the donor cells. In a study of mouse cloning from myoblasts, the clones continued to express muscle-specific genes and showed a greater preference for somatic cell culture media than embryo culture media (Gao et al., 2003) . Because the electrofusion method used in this study also delivers full amounts of donor cell membrane (with epitopes, channels, transporters, etc.), mRNA and protein to the clone, we do not know if it would also hold true in cases of direct nucleus injection. Therefore, in addition to the pluripotencyassociated genes, we have also analyzed the cumulus cellspecific transcripts prostaglandin-endoperoxide synthase 2 (Ptgs2) and Tumor necrosis factor alpha-induced protein 6 (Tsg6) (Fulop et al., 1997; Gui and Joyce, 2005) . We found that mRNAs are still present at the morula stage but not at the blastocyst stage in clones, although their level is several orders of magnitude lower than in cumulus cells. Ptgs2 and Tsg6 should be extinguished rapidly after nuclear transfer, but silencing may in fact not be instantaneous due to 'epigenetic memory' of the somatic nucleus (Ng and Gurdon, 2005) . Clearly, the substantial differences of blastocyst and fetal development as well as ES cell formation observed among subsets of clones (Table 4) may not be ascribed to continuing expression of Ptgs2 and Tsg6 given how little mRNA is found at the blastocyst stage. However, since ES cells can be derived from morula (Tesar, 2005) and also from 8-cell stage (Chung et al., 2006) , future studies will characterize if and how ES cell formation from earlier stage cloned embryos is affected by residual somatic transcripts or proteins.
It has been proposed that DNA methylation, known to be variable among cell types, influences (or perhaps partially determines) their amenability to reprogramming (Santos et al., 2003) . Although there certainly is heterogeneity of DNA methylation of the Oct4 promoter in various somatic cell types (Marikawa et al., 2005) , its biological significance remains uncertain. The putative Nanog promoter is unmethylated while the Oct4 promoter is densely metylated in cumulus cells (Yamazaki et al., 2006) , yet this seems to give no edge to Nanog reprogramming since Nanog and Oct4 are expressed at comparable levels in NT embryos relative to ICSI control. Subsets of clones may not be resolved by the DNA methylation status of two of the Oct4 control regions: the basal promoter is entirely demethylated in all morulae regardless of origin and subset; the DE, which maintains Oct4 expression in the morula and should be demethylated at this stage, is substantially methylated in NT morulae in both subregions 2 and 4 in contrast to ICSI morulae, and with no differences between the subsets. Bisulfite data for the first exon do not show any obvious relationship to the level of Oct4 transcription. The minimal difference of DE methylation across subsets is consistent with the mRNA levels of Oct4, which are also very similar among clones. Showing that subsets of clones with different developmental ability are indistinguishable at the relevant Oct4 control regions, warns to think more carefully about the role of epigenetic factors as the main determinant of success after somatic cell nuclear transfer in an ooplasm. By contrast, difference of DE methylation between NT and ICSI mirrors the lower level of Oct4 in cloned morulae compared to ICSI morulae. We suggest that Oct4 is transcribed in different ways in ICSI and NT embryos, i.e. with and without recruitment of the DE, respectively. If hypermethylation of the DE prevented its engagement for Oct4 transcription, then it would also account for the low survival of cloned embryos in uterus. When these embryos are instead derived into ES cells, they undergo a tremendous selective pressure but also benefit from extended time for (re)setting of epigenetic marks in preparation for proper Oct4 gene expression.
In conclusion, we have shown that, after nuclear transfer from mouse cumulus cells, levels of Oct4-GFP intensity in cloned morulae define subsets that correlate with outcomes of development. This appears not to be the case for ICSI. It has been proposed that molecular mechanisms that activate pluripotency-associated genes in an embryo and that regulate long-term maintenance of expression in derivative ES cells are different (Rodda et al., 2005) . Accordingly, the interconnection of nodes of the pluripotency gene network may also be different when starting from a gametic nucleus compared to a somatic nucleus. Our results suggest a rather uniform course of reprogramming within the genes analyzed; across genes, there are differences that we cannot yet explain, although it is tempting to think that genes are reprogrammed independently of one another. The difference between a successful and a doomed cloned embryo corresponds with a slight difference of transcript level for Oct4, Nanog and Sox2. Should the concept of a quantitative effect of Oct4 (Hochedlinger et al., 2005; Niwa et al., 2000) also apply in nuclear reprogramming, it would be even more sensitive to level; the only way to induce substantial changes of gene expression levels in clones might be a change of the culture medium (Boiani et al., 2005) .
Experimental procedures
Mice
B6C3F1 (C57Bl/6J · C3H/HeN) oocytes were used as recipients for donor nuclei. OG2 mice harboring the Oct4-GFP transgene (Szabó et al., 2002) were deposited at the Jackson Laboratory by Dr. Jeffrey Mann (strain name B6;CBA-Tg(Pou5f1-EGFP)2Mnn/J; Stock No. 004654). F1(B6 · OG2) cumulus cells were used as somatic donors for cloning; OG2 sperm was used for intracytoplasmic sperm injection (ICSI). Mice used in this study were maintained and used for experimentation according to institutional guidelines.
Production of cloned embryos by somatic cell nuclear transfer (SCNT)
Eight week-old B6C3F1 female mice (Harlan Winkelmann, Germany) were superovulated with 7.5 international units (IU) of pregnant mare's serum gonadotropin (PMSG, Calbiochem cat. no. 367222) followed 48 h later by 7.5 IU of human chorionic gonadotropin (hCG, Calbiochem cat. no. 230734). Cumulus-oocyte complexes were collected 14-15 h post-hCG, and cumulus cells were removed enzymatically. Hyaluronidase (ICN cat. no. 151271, activity >5000 IU/mg) was used at 50 IU/mL in Hepes-buffered CZB medium, modified from the original recipe (Chatot et al., 1989) with 5.56 mM glucose, 20 mM Hepes, 5 mM sodium bicarbonate and 0.1% w/v polyvinylpyrrolidone (PVP, 40 kDa, Calbiochem cat. no. 529504) without bovine serum albumin (BSA). After incubation in a 100 lL drop of hyaluronidase solution for 20 min at 30°C (room temperature), the cumulus-free oocytes were removed, washed three times in Hepes-buffered CZB medium and then placed in a-MEM culture medium (see Section 4.4) until use. The cumulus cells of F1(B6 · OG2) mice were harvested analogously, then left in hyaluronidase and stored at 4°C for up to 4 h until use after adding an equal volume of a-MEM with BSA to the drop. Micromanipulations were performed at room temperature (30°C) on a glass-bottomed dish. For spindle removal ('enucleation'), 20 oocytes were placed in Hepes-buffered CZB medium (PVP 0.1% w/v; albumin-free) with 1 lg/mL cytochalasin B (Calbiochem cat. no. 250233; stock solution was 5 mg/mL in dimethylsulfoxide). The micropipette was pulled from borosilicate glass tubing (Clark Instruments, UK), cut blunt at 10-12 lm in diameter, backloaded with 5 lL of mercury, and driven by a piezo actuator (PMM 150 FU, PrimeTech, Japan) under DIC optics (Nikon, Japan). After removal of the spindle-chromosome complex, each oocyte was washed and left 1 h in 500 lL of a-MEM medium in 4-well plates (Nunc cat. no. 176740) at 37°C under 5% CO 2 in air. Transplantation of F1(B6 · OG2) cumulus cell nuclei was performed 1-2 h later in hypertonic (110%) Hepes-buffered CZB medium (as above, but with PVP 1% w/v). A group of 25 oocytes were processed for injection within a 10-min time span using an 8-10 lm blunt-end needle. After NT, oocytes were left to recover from possible mechanical trauma for 10 min on the microscope stage. They were then gently transferred to a 1:1 mixture of Hepes-buffered CZB and a-MEM medium and left there for 1-2 h at room temperature (30°C) before incubation in a-MEM medium at 37°C under 5% CO 2 in air. The reconstructed oocytes were then activated for 6 h in Ca-free a-MEM supplemented with 10 mM SrCl 2 (ICN cat. no. 152583), 5 lg/mL cytochalasin B and 0.2% w/v BSA. Presence of cytochalasin B was required to prevent extrusion of a polar body during oocyte activation. The resulting embryos are referred to as NT (nucleus-transplanted) embryos.
4.3.
Production of fertilized embryos by intracytoplasmic sperm injection (ICSI)
Because manipulation is known to affect expression of genes (Wrenzycki et al., 2005) , we used ICSI morulae that underwent invasive manipulation comparable to cloning as a control. Sperm and oocyte collection have been described (Boiani et al., 2002; Cavaleri et al., 2006) . ICSI was performed using B6C3F1 oocytes and OG2 sperm to match the F1(B6 · OG2) genomic background of the cumulus cell clones. Sperm head injections started at 11 am and were conducted in nuclear transfer medium. Injected oocytes were then gently moved to a 1:1 mixture of Hepes-buffered CZB and a-MEM media for 1-2 h at 30°C prior to incubating in a-MEM medium at 37°C under 5% CO 2 in air.
4.4.
In vitro culture of NT and ICSI embryos
The use of the a-MEM for the production of cloned mouse blastocysts has been reported (Boiani et al., 2005; Gao et al., 2003) . a-MEM has also been reported as a suitable medium for culture of fertilized mouse embryos (Roudebush et al., 1994; Wun et al., 1994) . a-MEM (Sigma cat. no. M4526; Wun et al., 1994) was supplemented with 0.2% w/v BSA (Pentex, Serologicals Proteins Inc., code no. 81-068, lot no. 742) and filtered through a cellulose acetate membrane (0.22 lM, Fisher cat. no. 09-719A; preconditioned with medium) prior to use. Embryos were cultured in groups of 50-100 in 500 lL of a-MEM medium with BSA in 4-well plates. Embryos were examined at the four-cell stage 48 h after onset of culture, and the medium was supplemented with an additional 100 lL of a-MEM to enhance further development. Seventy-eight hours post-ICSI or post-activation, embryos that had undergone compaction were considered to be morulae and used for GFP imaging. Formation of a cavity was taken as evidence for blastocyst.
Multicolor fluorescence in situ hybridization (M-FISH)
Preparation of chromosome spreads and M-FISH analysis were performed as described (Balbach et al., 2007; Boiani et al., 2005; Guo et al., 2005) .
Acquisition of GFP images
Live images of morulae expressing GFP were captured on the stage of a Nikon Eclipse 2000-U inverted microscope coupled with a fast scanner laser device based on Yokogawa multi-pinhole spinning Nipkow disk (Perkin-Elmer Ultra View RS3). Morulae were placed individually in 1.0 lL drops of a-MEM, arrayed 5 · 5 on a 50 mm thin-bottom plastic dish (Greiner Bio-One, Lumox dish cat. no. 96077303) suitable for short working distance immersion lenses, and overlaid with embryo-tested mineral oil (Sigma cat. no. M5310) that had been washed extensively with MilliQ water.
A Tokai-Hit environmental mini-chamber maintained a gas phase of 5% CO 2 in air at 37°C. For each morula, five confocal sections were captured in fluorescence mode 5 lm apart at the equatorial region. Maximum projection images were analyzed and stored in order to subsequently match the pattern of GFP expression in morulae with the ability to form blastocyst (see Section 4.7).
A Nikon CFI Plan Apochromat VC 60X WI objective lens (N.A. 1.20) was used to convey 488 nm laser excitation to the GFPexpressing embryo. The source was a 3-line (488, 568 and 647 nm) Argon/Krypton laser (Melles Griot). Laser power at 488 nm was 4.3 mW at the lens. No auxiliary lens (e.g. Optovar) or optical device (e.g. filter) was present in the optical path except for the UltraView's own, and the laser was not attenuated (100% AOTF). Optical sections were captured using a 1.3 megapixel Hamamatsu ORCA ER digital camera with standardized settings (999 ms camera exposure, 2 · 2 binning hence 672 · 512 image pixels, no electronic gain).
Analysis of GFP images
For each morula, the five GFP confocal sections were combined (maximum projection) and analyzed with ImageJ (a free software by W.S. Rasband, U.S. National Institutes of Health, Bethesda, Maryland, USA, http://rsb.info.nih.gov/ij /, 1997-2006) . Using the polygon selection tool of ImageJ, a region of interest (ROI) was drawn by hand that included only pixels belonging to the embryo (Supplementary Figure 1 ). ROI area, mean intensity, standard deviation, skewness and kurtosis were measured for each embryo.
Derivation of ES cell lines
After digestion of the zonae pellucidae with acidic Tyrode's solution, blastocysts were transferred in groups of 4-5 onto STO-SNL cell feeder layers in 4-well dishes and left for 2-4 days without passage. At 6-8 days from the initial NT or ICSI, blastocysts attached to feeders and formed trophoblastic outgrowths. Then the ICMs were selectively removed with a polished glass Pasteur pipette. Isolated masses were replated after trypsinization with 0.25% trypsin, 1 mM EDTA onto a 96-well dish covered with mitotically arrested MEF feeders. ES cells were grown to subconfluency and gradually expanded by subsequent passages of trypsinization, dissociation and replating onto freshly prepared MEF feeders, scaling up to larger well sizes. Typically, passage zero (the one after the initial dissociation/replating of the ICM) took 5-6 days; subsequent passages took 2-3 days. The medium for blastocyst outgrowth formation and ES cell culture consisted of D-MEM high glucose (Invitrogen, cat. no. 11960-044), 15% FCS (HyClone, ANF190A9), 0.1 mM MEM non-Essential amino acids (Invitrogen Cat. no. 11140-050), 100 U/ml Pen-Strep, 2 mM L-glutamine, 0.1 mM b-mercaptoethanol and 10 4 U/ml LIF. Feeder cells, whether STO-SNL or MEF, were mitotically arrested by a 2 h treatment with mitomycin C at 10 lg/ml.
Immunocytochemistry of embryos and ES cells
Unless noted otherwise, all steps were carried out at 4°C in PBT, with washing twice in PBT for 5 min at ambient temperature between subsequent steps. Embryos were fixed in paraformaldehyde (PFA, MP Biomedicals, 1% in PBS) for 1 h. After washing, the plasma membrane was permeabilized with Triton-X 100 (0.1% v/ v) for 20 min. Unspecific binding sites were blocked overnight using BSA (2% w/v); the blocking solution also contained glycine (2% w/v) to quench residual PFA-activity. Without washing, specimens were then transferred into a 1:5000 dilution of the primary antibody (mouse anti-Oct4 monoclonal IgG 2b , Santa Cruz sc-5279) in an extended blocking solution (0.5% BSA, 0.5% glycine) and incubated overnight. The secondary donkey antibody coupled to Alexa fluorophore 568 was used at a dilution of 1 lg/mL at ambient temperature for 1-2 h. Specimens were washed twice, counterstained for DNA (5 lM DRAQ5, BioStatus, UK), and examined by spinning disk laser confocal microscopy.
ES cells were fixed in 4% PFA for 20 min. and subsequently rinsed in PBS 1X. For Oct4 and SSEA-1 immunostaining, fixed cells were blocked for 1 h with 3% BSA and 0.1% TritonX (Oct4) or 3% BSA and 0.01% Tween 20 (SSEA-1) in PBS. Then they were incubated for 2 h with a 1:200 dilution of anti-Oct4 monoclonal mouse antibody (Santa Cruz sc-5279) or a 1:100 dilution of anti-SSEA-1 monoclonal mouse antibody (Hybridoma Bank, MC-480) in blocking solution. After rinsing/washing for 30 min in blocking solution, cells were incubated for 30 min with a 1:100 dilution of anti-mouse secondary antibody IgG-Cy3 (Jackson ImmunoResearch, 315-166-047) in PBS and washed again three times in PBS. For TNAP staining, fixation and staining were performed according to manufacturer instructions (Alkaline Phosphatase Detection kit, Chemicon, SCR004).
In vivo development of cloned and chimeric fetuses
Transfer of zygotic and clonal blastocysts to the genital tract was performed essentially as previously described (Boiani et al., 2002) . Chimera formation and germline transmission after blastocyst injection served as conclusive scoring of ES cell lines. Therefore, the cavities of zygotic blastocysts at 96 h of development were microinjected with 10-15 clonal ES cells, on average, following a standard protocol (Nagy et al., 2003) , and then transferred into the uterus of 2.5 dpc pseudopregnant ICR females. Development rate and developmental contribution were assessed at 10.5 and 14.5 dpc for clones and injected blastocysts, respectively.
PCR analysis of cloned and chimeric fetuses
Gonads were removed where necessary. Carcasses were digested in 1 mL (E14.5 fetuses) or 100 lL (E10.5 fetuses) of 100 mM Tris pH 8.0, 0.5% Tween 20, 0.5% NP-40 and 0.2 mg/mL proteinase K at 55°C. DNA was diluted 1:100, and 1 lL of the dilution was analyzed for detection of the GFP transgene by a 30 cycle PCR with the primers 5 0 -TGAAGTTCATCTGCACCACC-3 0 and 5 0 -TCACCTT GATGCCGTTCTTC-3 0 (amplicon size 360 bp).
Analysis of gene expression by real time RT-PCR
For real time analysis of gene expression, embryos were harvested, processed and analyzed as previously described (Boiani et al., 2005) . Briefly, total RNA was extracted from pools of 10 blastocysts using the MicroRNeasy Kit (Qiagen GmbH, Hilden, Germany), according to the manufacturer's instructions. RNA sample was treated with DNase to avoid amplifying products from genomic DNA. Complementary DNA synthesis was performed with the High Capacity cDNA Archive Kit (Applied Biosystems GmbH, Darmstadt, Germany) following the manufacturer's instructions, but scaling down the reaction volume to 20 ll. Transcript levels were determined using the ABI PRISM Sequence Detection System 7900 (Applied BioSystems) and the ready-touse 5 0 -nuclease Assays-on-Demand. For each real time amplification, the template was equivalent to 1/4 of a blastocyst. Measurements were done in triplicate. Amplification curves and gene expression were normalized to the housekeeping gene Hprt, which we used as an internal standard because we found it to be more stable than others we had previously tested.
Primers for the following genes were designed by the Taqman Assay-on-Demand: Pou5f1 (Mm00658129_gH), Sox2 (Mm0048 8369_s1), Cdx2 (Mm00432449_m1), Pou2f1 (Mm00448332_m1), Tbp (Mm00446973_m1), Ptgs2 (Mm00478374_m1), Tnfaip6 (Mm00493736_m1) and Hprt1 (Mm00446968_m1). Oligos for Nanog amplification were customly designed (PF: 5 0 -AACCAGTGGTTG AATACTAGCAATG-3 0 , PR: 5 0 -CTGCAATGGATGCTGGGATACT-3 0 , Probe: 5 0 -6FAM-TTCAGAAGGGCTCAGCAC-MGB-3 0 ). Three replicates were used for each real time PCR reaction; an RT À blank and a no-template blank served as negative controls. Quantification was normalized on the endogenous Hprt gene within the loglinear phase of the amplification curve obtained for each probe/ primer using the DDCt method (ABI PRISM 7700 Sequence Detection System, user bulletin #2).
4.13. Genomic DNA isolation, bisulfite mutagenesis, PCR amplification and sequencing
Embryos were transferred into 100 ll lysis buffer containing 5 lL proteinase K (20 mg/mL) and incubated at 55°C overnight. Genomic DNA was recovered from the lysate by ethanol precipitation after the addition of 5 lg tRNA as carrier and dissolved in 10 lL milliQ water. Isolated genomic DNA was digested with Bam-HI in 20 lL of reaction buffer for 16 h and denatured with 0.3 N NaOH. Then, 235 lL of 5 M sodium bisulfite (pH 5) and 13.5 lL of 10 mM hydroquinone were added. The reaction mixture was overlaid with mineral oil and incubated at 55°C for 16 h in the dark. The bisulfite-treated genomic DNA was purified with PCR purification kit (Qiagen) according to the manufacturer's protocol, diluted with 50 lL of 90°C distilled water and then eluted by centrifugation at 12,000g. The DNA sample was mixed with 4.4 lL of 3 N NaOH and incubated at 37°C for 30 min. Following precipitation, the DNA was dissolved in 20 lL milliQ water.
Two subregions of the distal enhancer (GenBank Accession No. AF111103) and one subregion each of the basal promoter and exon 1 (GenBank Accession No. S58422) of the mouse Oct4 gene were selected based on Hattori et al. (2004) (Supplementary Figure  4) . Amplicons were generated using the following PCR conditions; 45 cycles of 94°C for 30 s, 48-50°C for 60 s, and 72°C for 60 s in the first PCR and then another 35 cycles of 94°C for 30 s, 50°C for 30 s, and 72°C for 30 s in the nested PCR. For primer sequences refer to Supplementary Table 2. The resulting PCR products were cloned into the pGEM T-easy vector (Promega) and then sequenced using ABI PRISM-377. We analyzed the lower DNA strand (G!A conversion). (Bailey, 1959) .
Statistical analysis
